0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

MEDICINE AND THE WAR

JAMA. 1944;125(14):977-978. doi:10.1001/jama.1944.02850320035013.
Text Size: A A A
Published online

ABSTRACT

QUINACRINE HYDROCHLORIDE (ATABRINE) FOR MALARIA  On May 31, 1944 the Board for the Coordination of Malarial Studies adopted the following resolution concerning the relative value to the armed forces of quinacrine hydrochloride, U. S. P. (atabrine), quinine and totaquine, U. S. P.On the basis of controlled quantitative studies in civilian, Army and Navy establishments, the evidence at hand justifies the following statement:

  1. In the Suppressive Therapy.—Quinacrine (atabrine) has proved to have all the antimalarial properties ascribed to quinine in the suppression of malaria during and subsequent to exposure to infected mosquitoes. Effective suppression can be accomplished over long periods of time by proper use of quinacrine. Available evidence indicates that this end may be achieved without danger to the individual.

    Earlier reports indicated a significant incidence of gastrointestinal disturbances in certain groups of men receiving suppressive quinacrine therapy. For practical purposes these adverse reactions can be avoided by

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();